Rheumatology NewsOlokizumab proves noninferior to adalimumab for RA in phase 3 trialAugust 24, 2022Rheumatoid Arthritis
Rheumatology NewsAsian patients with psoriasis have shortest visits, study showsAugust 24, 2022Psoriatic ArthritisDiversity in Medicine
Rheumatology NewsWords, now actions: How medical associations try to fulfill pledges to combat racism in health careAugust 22, 2022Diversity in Medicine
PsA remission depends on patient perception and is multidimensionalAugust 21, 2022Psoriatic Arthritis
Clinically meaningful improvement in PRO with risankizumab vs placebo in PsAAugust 21, 2022Psoriatic Arthritis
Nail dystrophy predicts response to secukinumab in PsA patients with axial manifestationsAugust 21, 2022Psoriatic Arthritis
Nail disease and dactylitis influence treatment response in patients receiving etanercept or methotrexateAugust 21, 2022Psoriatic Arthritis
Golimumab effective as second-line anti-TNFα treatment in the real-worldAugust 21, 2022Psoriatic Arthritis
